This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Insulin Aspart 100 Unit/ML VL 10ML. The contract has a firm fixed price of $4,746.50 and a completion date of January 19, 2024. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical division. This IDC serves...
This federal contract award, valued at $2,371.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML, a critical medical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award, valued at $16,257.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and covers the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,433.76, is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML, a medical product used for diabetes management. The contract has a ceiling value of $41,682.05 and a period of performance through November 21, 2023. This contract is a firm fixed price delivery order issued under...
This federal contract award, with a ceiling value of $26,133.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML medical supplies, with a performance period ending on January 17, 2024. This contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with any set-aside requirements, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,610.83 firm fixed-price delivery order is for the supply of INSULIN ASPART 100 UNIT/ML PEN 3ML medical products. The contract has an ultimate completion date of December 26, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $13,645.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract covers the delivery of 4563225373 INSULIN ASPART 100 UNIT/ML PEN 3ML, with a completion date of January 4, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,245.58, is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL. The contract is a Firm Fixed Price type and has an ultimate completion date of December 18, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award is for the delivery of INSULIN ASPART 100 UNIT/ML PEN 3ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $12,160.25. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...